In addition, our preliminary research has also found that Cpn improved metabolic inflammation by acting on the colon and intestinal flora, and metabolic inflammation has been considered a key driver of obesity (Chen et al., 2022a). Here, CPN1 is linked to obesity due to melanocortin 4 receptor deficiency.